Literature DB >> 23564334

Validation and cross-cultural adaptation of the Self-Assessment Disability Scale in patients with Parkinson's disease in Serbia.

Tatjana Gazibara1, Iva Stankovic, Aleksandra Tomic, Marina Svetel, Darija Kisic Tepavcevic, Vladimir S Kostic, Tatjana Pekmezovic.   

Abstract

The symptoms of Parkinson's disease (PD) worsen over time affecting performance and causing disability. The purpose of this study was to translate the Self-Assessment Disability Scale in patients with Parkinson's disease (SADS-PD) into the Serbian language and assess its validity and reliability. From January to July 2012, 114 consecutive PD patients were recruited at the Neurology Clinic in Belgrade. The inclusion criteria were: ability to walk independently for at least 10 m, ability to stand for at least 90 s. The exclusion criteria were: cognitive impairment, the presence of other major neurologic, psychiatric, visual, audio-vestibular, and orthopedic disturbances. The 25-item SADS-PD was translated according to internationally-accepted methodology. The internal consistency of the scale was evaluated using Cronbach's alpha coefficient. Test-retest reliability was evaluated using Kendall's concordance coefficient for total scores. To evaluate construct validity, an exploratory factor analysis (principal component analysis, varimax rotation) was performed. Cronbach's alpha coefficient was 0.984. Kendall's concordance coefficient was 0.994. Duration of the disease, Hoehn & Yahr (H&Y) stage, Unified Parkinson's Disease Rating Scale (UPDRS) motor score, history of falls, Hamilton's Depression and Anxiety Rating Scales (HDRS and HARS) scores were significantly correlated with the total SADS-PD score. On factor analysis 25 items in the SADS-PD questionnaire were separated in two clusters with total matrix variance of 79.7 %. The psychometric properties of the cross-culturally adapted SADS-PD questionnaire (Serbian version) have outstanding validity and reliability as an instrument for evaluation of the extent of disability in patients with PD.

Entities:  

Mesh:

Year:  2013        PMID: 23564334     DOI: 10.1007/s00415-013-6906-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Can focusing on UPDRS Part II make assessments of Parkinson disease progression more efficient?

Authors:  Cristina Sampaio
Journal:  Nat Clin Pract Neurol       Date:  2009-03

2.  Prevalence of non-motor symptoms in young-onset versus late-onset Parkinson's disease.

Authors:  Vladana Spica; Tatjana Pekmezović; Marina Svetel; Vladimir S Kostić
Journal:  J Neurol       Date:  2012-07-22       Impact factor: 4.849

3.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

4.  Cross-cultural adaptation and validation of health status measures.

Authors:  F Guillemin
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

7.  UPDRS activity of daily living score as a marker of Parkinson's disease progression.

Authors:  Madaline B Harrison; Scott A Wylie; Robert C Frysinger; James T Patrie; Diane S Huss; Lillian J Currie; G Frederick Wooten
Journal:  Mov Disord       Date:  2009-01-30       Impact factor: 10.338

Review 8.  Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Authors:  Maria C Rodriguez-Oroz; Marjan Jahanshahi; Paul Krack; Irene Litvan; Raúl Macias; Erwan Bezard; José A Obeso
Journal:  Lancet Neurol       Date:  2009-12       Impact factor: 44.182

Review 9.  Non-motor dysfunction in Parkinson's disease.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Parkinsonism Relat Disord       Date:  2007-03-08       Impact factor: 4.891

10.  Making sense of Cronbach's alpha.

Authors:  Mohsen Tavakol; Reg Dennick
Journal:  Int J Med Educ       Date:  2011-06-27
View more
  4 in total

1.  Incidence and prediction of falls in Parkinson's disease: a prospective cohort study.

Authors:  Tatjana Gazibara; Tatjana Pekmezovic; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir S Kostic
Journal:  Eur J Epidemiol       Date:  2015-03-18       Impact factor: 8.082

2.  Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir Kostic; Tatjana Pekmezovic
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

3.  Psychometric Evaluation of the Parkinson's Disease Activities of Daily Living Scale.

Authors:  Stina B Jonasson; Peter Hagell; Gun-Marie Hariz; Susanne Iwarsson; Maria H Nilsson
Journal:  Parkinsons Dis       Date:  2017-09-25

Review 4.  Assessment tools to evaluate Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) in older adults: A systematic review.

Authors:  Marzieh Pashmdarfard; Akram Azad
Journal:  Med J Islam Repub Iran       Date:  2020-04-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.